SOX5 is a transcription factor that functions primarily in chondrocyte differentiation and cartilage development. It binds the 5'-AACAAT-3' DNA motif in enhancers and super-enhancers to promote expression of cartilage-specific genes including COL2A1 and AGC1 1. SOX5 cooperates with SOX6 and SOX9 as part of the "chondrogenic SOX Trio" to potentiate transactivation of cartilage genes during overt chondrogenesis, maintaining proliferating chondroblasts and regulating hypertrophy and terminal differentiation 1. Beyond skeletal development, SOX5 serves as a key transcriptional regulator in synovial fibroblast differentiation trajectories and is predicted to regulate the emergence of specialized lining fibroblasts from mesenchymal progenitors 2. Recently, SOX5 was identified as a potent driver of cellular rejuvenation; its overexpression resets transcription networks for geroprotective genes like HMGB2, and SOX5 gene therapy alleviated osteoarthritis in aged mice 3. Additionally, SOX5 has been implicated in neurodevelopmental processes, with genetic associations to neuropsychiatric disorders and risk factors including suicide attempt 45. Heterozygous SOX5 alterations cause Lamb-Shaffer syndrome, a neurodevelopmental disorder characterized by variable intellectual disability and language delay; missense variants in the HMG domain prevent DNA binding and transactivation 6.